The off-target effects of nonspecific NK cells

Blood

Volumn 125, Issue 5, 2015, Pages 744-745

  Lee, Dean A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; CANCER CELL; CD34 SELECTION; CELL MATURATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HELPER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; NATURAL KILLER CELL; NOTE; PRIORITY JOURNAL; T CELL DEPLETION; TARGET CELL; UPREGULATION; FEMALE; GASTROINTESTINAL NEOPLASMS; MALE; PATHOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROCEDURES; SKIN NEOPLASMS; TRANSPLANTATION;

CD137 LIGAND; IL15 PROTEIN, HUMAN; INTERLEUKIN 15;

4-1BB LIGAND; FEMALE; GASTROINTESTINAL NEOPLASMS; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-15; KILLER CELLS, NATURAL; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SKIN NEOPLASMS;

EID: 84921755987     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-12-616359     Document Type: Note

References (7)

1. Shah NN, Baird K, Delbrook CP, et al. Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell -depleted stem cell transplantation. Blood. 2015;125(5):784-792.
2. Venstrom JM, Gooley TA, Spellman S, et al. Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood. 2010; 115(15):3162-3165.
3. Giebel S, Nowak I, Dziaczkowska J, et al. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation. Eur J Haematol. 2009;83(4):343-356.
4. Savani BN, Mielke S, Adams S, et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia. 2007;21(10): 2145-2152.
5. Kim DH, Sohn SK, Lee NY, et al. Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors. Eur J Haematol. 2005;75(4):299-308.
6. Bachanova V, Cooley S, Defor TE, et al. Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein. Blood. 2014;123(25):3855-3863.
7. Choi I, Yoon SR, Park SY, et al. Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a doseescalation study. Biol Blood Marrow Transplant. 2014;20(5):696-704.